This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

GSK has partnered with experts across healthcare to offer webinars and events on the subjects that matter to you. If you missed the live event, you will find our on-demand webinars in the ‘past’ tab below

Filter By
Reset all
Products
  • General Vaccine Unbranded

  • Trelegy

  • Vaccines

Therapy
  • Severe asthma

  • Asthma

  • COPD

  • Oncology

  • Vaccines

  • Immunology

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

Optimising the Paediatric Severe Asthma Journey
Speakers: Dr Deb Marriage, Angela Jamalzadeh, Dr Prasad Nagakumar, Dr Pujan Patel
Four severe asthma experts discuss key aspects of the paediatric severe asthma journey. Topics covered include who, when and why to refer to a paediatric severe asthma service, the adolescent homecare service, and transitioning from adolescent to adult service.
02 Dec, 2021 o 17:00 GMT
February 2022 | PM-GB-MPL-WCNT-210026 (V1.0)
Filter By
Reset all
Products
  • General Vaccine Unbranded

  • Trelegy

  • Vaccines

Therapy
  • Severe asthma

  • Asthma

  • COPD

  • Oncology

  • Vaccines

  • Immunology

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

Optimising the Paediatric Severe Asthma Journey
Speakers: Dr Deb Marriage, Angela Jamalzadeh, Dr Prasad Nagakumar, Dr Pujan Patel
Four severe asthma experts discuss key aspects of the paediatric severe asthma journey. Topics covered include who, when and why to refer to a paediatric severe asthma service, the adolescent homecare service, and transitioning from adolescent to adult service.
02 Dec, 2021 o 17:00 GMT
February 2022 | PM-GB-MPL-WCNT-210026 (V1.0)

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441